ArticleJournal of molecular modeling2025
Molecular dynamics simulation of TNT/PYRN cocrystal PBXs.
Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular dynamics simulation of TNT/ATL cocrystal morphology under different conditions.Journal of molecular modeling · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextThe ternary eutectic system comprising trinitrotoluene (TNT) and pyranidine (PYRN) exhibits potential as a moderate-energy explosive compound characterized by reduced sensitivity. Recently, this composition can be a suitable alternative to TNT in the development of low-vulnerability explosive formulations, thus providing a promising alternative for future applications in the field of energetic materials. However, the changes in the structure and properties of eutectic explosives and their intrinsic causes for these changes have been rarely explored. Here, we construct a theoretical model of the TNT/PYRN eutectic system and integrates a diverse array of polymer additives, including butadiene rubber (BR), ethylene-vinyl acetate copolymer (EVA), polyethylene glycol (PEG), fluorinated polymer (F2603), and polyvinylidene fluoride (PVDF), into five distinct cleavage planes ((1 0 0), (0 1 0), (0 1 - 1), (1 0 0), and (1 0 - 1)) within the eutectic matrix. We found that the synthesis of polymer-bonded explosives (PBXs) is achieved through the integration of the aforementioned polymers into the TNT/PYRN eutectic system. This investigation elucidated the influence of various polymer matrices on the structural integrity, critical bond distances for initiation, mechanical attributes, and detonative behavior of the resultant PBXs. Within the corpus of five PBX models examined, the TNT/PYRN/F2603 configuration showed the supremum in binding energetics and the infimum in critical bond lengths, which portends superior stability, interfacial harmony, and a minimized propensity for unintended initiation. Furthermore, the TNT/PYRN/F2603 system was delineated by its enhanced capability for explosive initiation. Note importantly that the TNT/PYRN/F2603 model exhibited pre-eminence in its aggregate performance metrics, corroborating the hypothesis that F2603 constitutes a preferential binder candidate for PBX formulations predicated on the TNT/PYRN eutectic composite.
methodsUtilizing the Materials Studio computational platform, the physicochemical attributes of the TNT/PYRN eutectic-based polymer-bonded explosives (PBXs) were anticipated via molecular dynamics (MD) simulations. The MD protocol was executed with a temporal increment of 1 fs, encompassing an aggregate simulation span of 2 ns. An isothermal-isobaric (NPT) thermodynamic ensemble was employed for the duration of the 2 ns MD trajectory. The COMPASS empirical force field was utilized to model interatomic interactions, and the thermal parameter was maintained at a constant 295 K throughout the simulation campaign.
Indexed as
Identifiers
40387975What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.